Cathie's Ark Logo
Personalis Inc Logo

ARKG Holdings of Personalis (PSNL) - Updated Daily

Liquid BiopsyGenomicsGenetic Testing
Date
Direction
Shares
Fund Weight
Fund
May 2, 2023
BUY90.849k0.0111%ARKG
May 1, 2023
BUY14.638k0.0018%ARKG
April 28, 2023
BUY80.334k0.0099%ARKG
March 1, 2023
BUY64.623k0.0091%ARKG
February 28, 2023
BUY1.099k0.0002%ARKG

Key Statistics

⚖️Weighting🧢Market Cap
0.53%$89.82m
🏋🏿‍♂️Weight Rank In ARKG🌏Country
37🇺🇸United States
🏋️‍♀️Weight Rank Across All Funds💳ARK Estimated Cost Average
100
🎫ARK Ownership Percent
12.24%
Description
personalis is a genome-scale diagnostics company with a mission to pioneer genome guided medicine. our priority is to obtain the most accurate genetic data from each sample, and then to draw the most reliable medically-focused conclusions from these. our tests are based on whole human genome and exome sequencing, conducted in our state-of-the art laboratory. we analyze results utilizing proprietary databases, advanced human reference sequences, and sophisticated algorithms. personalis genome services provides academic, pharmaceutical, and biotech researchers an accurate and comprehensive end-to-end human genome sequencing and analysis solution. our services support researchers engaging in large case-control and family-based genome studies of complex or mendelian diseases and traits, pharmacogenomics, and cancer.
Website
personalis.com

Other ETFs That Hold PSNL

Ticker
NameWeight
ARKGARK Genomic Revolution ETF0.83%

Research Notes and Commentary for PSNL

No Research Notes Found for PSNL